Aldeyra Therapeutics, Inc. (ALDX) Balance Sheet
As of 2026-06-30 (10-Q), Aldeyra Therapeutics, Inc. (ALDX) reported total assets of $47.5M, total liabilities of $9.7M and shareholders' equity of $37.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $45.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALDXAldeyra Therapeutics, Inc.Follow ALDX — free
—
Price chart with a free account
- Market cap
- 39.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.5 | 14.6 | 12.0 | 20.0 | 47.4 | 44.4 | 77.9 | 229.8 | 144.4 | 142.8 | 54.5 | 70.0 | 45.1 | |
| Short-term investments | — | 12.9 | 12.9 | 22.9 | 46.2 | 28.9 | 0.0 | 0.0 | 29.9 | 0.0 | 46.6 | 0.0 | — | |
| Current assets | 8.8 | 28.1 | 25.1 | 44.0 | 94.8 | 75.2 | 83.1 | 232.8 | 181.0 | 147.8 | 104.1 | 71.8 | 47.4 | |
| Total assets | 8.8 | 28.2 | 25.2 | 44.2 | 95.1 | 75.5 | 83.4 | 233.1 | 181.3 | 148.3 | 104.6 | 72.1 | 47.5 | |
| Current liabilities | 1.3 | 2.1 | 2.3 | 3.4 | 8.5 | 12.9 | 12.4 | 11.8 | 15.4 | 22.3 | 18.6 | 27.8 | 9.7 | |
| Long-term debt | 1.4 | 1.4 | 1.4 | 1.4 | 16.0 | 16.0 | 16.0 | 16.0 | 14.9 | 0.0 | 15.0 | 0.0 | — | |
| Short-term debt | 0.1 | 0.1 | 0.1 | 0.1 | — | — | — | — | 0.9 | 15.1 | 0.0 | 15.2 | 0.0 | |
| Total liabilities | 2.5 | 3.3 | 3.5 | 4.6 | 8.5 | 27.4 | 23.8 | 27.4 | 30.3 | 28.5 | 33.6 | 27.8 | 9.7 | |
| Shareholders' equity | 6.3 | 24.9 | 21.6 | 39.6 | 86.6 | 48.1 | 59.5 | 205.7 | 151.0 | 119.8 | 71.0 | 44.3 | 37.9 |
USD millions · SEC XBRL
Aldeyra Therapeutics, Inc. — questions
- How much cash does Aldeyra Therapeutics, Inc. have?
- $45.1M in cash and cash equivalents as of 2026-06-30.
- How much debt does Aldeyra Therapeutics, Inc. have?
- $0 due within a year as of 2026-06-30.
- What are Aldeyra Therapeutics, Inc.'s total assets?
- $47.5M as of 2026-06-30.
- What is Aldeyra Therapeutics, Inc.'s shareholders' equity?
- $37.9M as of 2026-06-30.
Every figure on this page comes from Aldeyra Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.